The pre-announcement de-risks Q3 results ahead of the Nov 10 earnings call. Watch for full Q3 financials including EPS, margins, and cash flow, as well as commentary on whether the large customer's accelerated purchasing is a pull-forward or a sustainable demand signal.
Price Chart
Executive Summary
MaxCyte reported preliminary Q3 2026 core revenue of ~$8.1M (+26% YoY) and raised full-year 2026 revenue guidance to ~$34M from $30-32M, driven by accelerated instrument purchasing from a large customer and a second SPL milestone. The pre-announcement signals a return to double-digit core revenue growth in H2 2026, a positive reversal from the 25% YoY core revenue decline in Q1 2026.
Key Financial Metrics
Key Facts
- Preliminary Q3 2026 core business revenue of approximately $8.1 million, up 26% YoY from Q3 2025.
- Full-year 2026 revenue guidance raised to approximately $34 million from prior guidance of $30-32 million.
- Core business revenue guidance raised to ~$28 million from $25-27 million; SPL Program-related revenue guidance raised to ~$6 million from ~$5 million.
- Q3 2026 SPL milestone revenue of $1.0 million received; royalty revenue to be reported with full Q3 results on Nov 10, 2026.
- CEO cited accelerated instrument purchasing from a large customer originally expected in Q4 as a key driver of Q3 outperformance.
Financial Impact
Full-year revenue guidance raised by ~$2-4M to ~$34M; Q3 core revenue growth of 26% YoY vs a 25% decline in Q1 2026.
Risk Factors
- Results are preliminary and unaudited; actual Q3 figures may differ when reported on Nov 10, 2026.
- Q3 outperformance was partly driven by a large customer's accelerated purchasing from Q4 purchases, which may not recur in Q4.
- Core revenue growth is still recovering from a 25% YoY decline in Q1 2026; sustainability of double-digit H2 growth is not yet confirmed.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-115745 |
| Document: tm2627568d1_ex99-1.htm | 0001104659-26-115745 |
| Document: 0001104659-26-115745-index-headers.html | 0001104659-26-115745 |
| Document: 0001104659-26-115745-index.html | 0001104659-26-115745 |
| Document: 0001104659-26-115745.txt | 0001104659-26-115745 |
| 8-K Data (Synthetic) | 0001104659-26-115745 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | SC 13D | $1.30 $1.43 | ▲ +10.00% | ▲ +11.01% | $1.54 (+18.46%) |
Oct 14, 2026 13d ago | 8-K | $1.25 $1.47 | ▲ +17.60% | ▲ +17.15% | $1.54 (+23.20%) |
Apr 29, 2026 25w ago | DEFA14A | $0.8800 $0.8720 | ▼ −0.91% | ▼ −2.64% | $1.54 (+75.00%) |
Mar 24, 2026 31w ago | Press Release | $0.6900 $0.7440 | ▼ −7.83% | ▼ −8.07% | $1.54 (−123.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers